vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and GEN Restaurant Group, Inc. (GENK). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $49.7M, roughly 1.2× GEN Restaurant Group, Inc.). GEN Restaurant Group, Inc. runs the higher net margin — -3.8% vs -70.9%, a 67.1% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -9.0%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-5.6M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -1.0%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Gen Korean BBQ is an American chain of all-you-can-eat Korean barbecue restaurants mainly concentrated around the Western U.S. It opened in 2011, and has since grown to 43 locations as of 2024.
CTKB vs GENK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $49.7M |
| Net Profit | $-44.1M | $-1.9M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | -24.5% |
| Net Margin | -70.9% | -3.8% |
| Revenue YoY | 8.1% | -9.0% |
| Net Profit YoY | -557.1% | -821.4% |
| EPS (diluted) | — | $-0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $49.7M | ||
| Q3 25 | $52.3M | $50.4M | ||
| Q2 25 | $45.6M | $55.0M | ||
| Q1 25 | $41.5M | $57.3M | ||
| Q4 24 | $57.5M | $54.7M | ||
| Q3 24 | $51.5M | $49.1M | ||
| Q2 24 | $46.6M | $53.9M | ||
| Q1 24 | $44.9M | $50.8M |
| Q4 25 | $-44.1M | $-1.9M | ||
| Q3 25 | $-5.5M | $-566.0K | ||
| Q2 25 | $-5.6M | $-261.0K | ||
| Q1 25 | $-11.4M | $-301.0K | ||
| Q4 24 | $9.6M | $-206.0K | ||
| Q3 24 | $941.0K | $25.0K | ||
| Q2 24 | $-10.4M | $277.0K | ||
| Q1 24 | $-6.2M | $496.0K |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | -24.5% | ||
| Q3 25 | -17.6% | -7.4% | ||
| Q2 25 | -23.3% | -3.4% | ||
| Q1 25 | -36.1% | -3.8% | ||
| Q4 24 | 5.2% | -2.4% | ||
| Q3 24 | -8.2% | 0.2% | ||
| Q2 24 | -18.3% | 3.0% | ||
| Q1 24 | -23.9% | 0.2% |
| Q4 25 | -70.9% | -3.8% | ||
| Q3 25 | -10.5% | -1.1% | ||
| Q2 25 | -12.2% | -0.5% | ||
| Q1 25 | -27.5% | -0.5% | ||
| Q4 24 | 16.8% | -0.4% | ||
| Q3 24 | 1.8% | 0.1% | ||
| Q2 24 | -22.4% | 0.5% | ||
| Q1 24 | -13.8% | 1.0% |
| Q4 25 | — | $-0.37 | ||
| Q3 25 | — | $-0.11 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | — | $-0.06 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | — | $0.01 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | — | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $2.8M |
| Total DebtLower is stronger | — | $13.6M |
| Stockholders' EquityBook value | $341.7M | $26.5M |
| Total Assets | $461.5M | $259.9M |
| Debt / EquityLower = less leverage | — | 0.51× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $2.8M | ||
| Q3 25 | $93.3M | $4.8M | ||
| Q2 25 | $75.5M | $9.6M | ||
| Q1 25 | $95.3M | $15.4M | ||
| Q4 24 | $98.7M | $23.7M | ||
| Q3 24 | $162.3M | $22.1M | ||
| Q2 24 | $177.9M | $29.2M | ||
| Q1 24 | $168.8M | $28.1M |
| Q4 25 | — | $13.6M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | — | $6.5M | ||
| Q4 24 | — | $6.9M | ||
| Q3 24 | — | $7.2M | ||
| Q2 24 | — | $7.6M | ||
| Q1 24 | — | $7.7M |
| Q4 25 | $341.7M | $26.5M | ||
| Q3 25 | $378.6M | $38.1M | ||
| Q2 25 | $377.6M | $41.0M | ||
| Q1 25 | $379.6M | $42.8M | ||
| Q4 24 | $395.7M | $44.1M | ||
| Q3 24 | $385.5M | $46.5M | ||
| Q2 24 | $389.1M | $45.9M | ||
| Q1 24 | $392.6M | $40.4M |
| Q4 25 | $461.5M | $259.9M | ||
| Q3 25 | $494.9M | $245.5M | ||
| Q2 25 | $493.3M | $246.3M | ||
| Q1 25 | $482.6M | $232.4M | ||
| Q4 24 | $499.5M | $240.4M | ||
| Q3 24 | $491.2M | $225.7M | ||
| Q2 24 | $483.7M | $218.8M | ||
| Q1 24 | $492.1M | $214.5M |
| Q4 25 | — | 0.51× | ||
| Q3 25 | — | 0.28× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.16× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.17× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $-426.0K |
| Free Cash FlowOCF − Capex | $-1.8M | $-5.6M |
| FCF MarginFCF / Revenue | -2.9% | -11.3% |
| Capex IntensityCapex / Revenue | 1.6% | 10.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-24.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $-426.0K | ||
| Q3 25 | $-3.9M | $-1.6M | ||
| Q2 25 | $108.0K | $3.3M | ||
| Q1 25 | $-125.0K | $2.2M | ||
| Q4 24 | $2.0M | $7.3M | ||
| Q3 24 | $13.2M | $1.4M | ||
| Q2 24 | $6.2M | $5.6M | ||
| Q1 24 | $4.0M | $3.5M |
| Q4 25 | $-1.8M | $-5.6M | ||
| Q3 25 | $-4.6M | $-7.7M | ||
| Q2 25 | $-1.5M | $-6.3M | ||
| Q1 25 | $-974.0K | $-4.7M | ||
| Q4 24 | $1.1M | $165.0K | ||
| Q3 24 | $12.2M | $-6.8M | ||
| Q2 24 | $5.2M | $1.2M | ||
| Q1 24 | $3.4M | $-586.0K |
| Q4 25 | -2.9% | -11.3% | ||
| Q3 25 | -8.7% | -15.3% | ||
| Q2 25 | -3.2% | -11.5% | ||
| Q1 25 | -2.3% | -8.2% | ||
| Q4 24 | 1.9% | 0.3% | ||
| Q3 24 | 23.7% | -13.9% | ||
| Q2 24 | 11.0% | 2.3% | ||
| Q1 24 | 7.6% | -1.2% |
| Q4 25 | 1.6% | 10.5% | ||
| Q3 25 | 1.3% | 12.0% | ||
| Q2 25 | 3.5% | 17.5% | ||
| Q1 25 | 2.0% | 11.9% | ||
| Q4 24 | 1.6% | 13.1% | ||
| Q3 24 | 2.0% | 16.9% | ||
| Q2 24 | 2.3% | 8.0% | ||
| Q1 24 | 1.3% | 8.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 57.96× | ||
| Q2 24 | — | 20.06× | ||
| Q1 24 | — | 7.08× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
GENK
Segment breakdown not available.
